Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Security class unavailable · CUSIP: 21077P108
Event date: 2024-05-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-24-002834
- Form type
- SC 13G
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- May 13, 2024
- Reporting period
- May 02, 2024
- Description
- Schedule 13G beneficial ownership